Skip to content
Monday, December 01, 2025
  • Business
  • Education
  • Entertainment
  • Health
  • Lifestyle
  • National
  • Press Release
  • Technology
Just News Now

Just News Now

  • Business
  • Education
  • Entertainment
  • Health
  • Lifestyle
  • National
  • Press Release
  • Technology
You are Here
  • Home
  • Optimus Pharma

Tag: Optimus Pharma

National Press Release

Optimus Announces Interim Clinical Results from Phase III Clinical Trials of Molnupiravir Conducted in India

July 21, 2021

Hyderabad (Telangana) [India], July 21: Optimus Pharma on Sunday submitted the interim result of Phase III Clinical Trials for orally administered Molnupiravir capsules on patients

Covid-19, D Srinivasa Reddy, DCGI, Drugs Controller General of India, Interim Clinical Results, Molnupiravir, Optimus Pharma, Phase III Clinical Trials, SARS-CoV-2

Recent Posts

  • 10 Extreme Banned Horror Films Exploring Psychological Limits
  • Atmaharaam Live — When the Hunt for Likes Becomes a Horror Story
  • The First Sci-Fi Thriller Based on Internet of Things and Artificial Intelligence Gets Part 2: Internet of Dangerous Things
  • SCIFF 2025 Hosts Special Screening of ‘Little Thomas’ in Mumbai as World’s Largest Children’s Film Festival Continues
  • UK-based Association of International Accountants (AIA) Announces Strategic Partnership with India’s Finprov Learning
  • Resset Launches RERA-Approved Project ‘Evara’, An Uber-Luxury Residential Landmark in South Bopal
  • Parul University Successfully Hosts the 3rd Edition of Its International Folklore Festival, Uniting 30 Nations in a Powerful Celebration of Global Harmony
  • SMART Introduces India-Manufactured Interactive Panels Designed on Universal Design for Learning Principles to Support Inclusive Classrooms
  • PNY Announces Local RMA Setup in India for NVIDIA GeForce and NVIDIA Professional GPUs in Partnership with Repair & Return Technology Pvt. Ltd.
  • From Popular Realty TV Show to IPO — Ravelcare Charts Its Next Big Leap with BSE SME Listing

Mail us : [email protected]

All Rights Reserved 2023.
Proudly powered by WordPress | Theme: Recent News by Candid Themes.